Accession Number:

AD1190952

Title:

AXL-Targeting Antibody-Drug Conjugate as Novel Therapy for Triple-Negative Breast Cancer

Descriptive Note:

[Technical Report, Annual Report]

Corporate Author:

UNIVERSITY OF SOUTHERN CALIFORNIA LOS ANGELES

Personal Author(s):

• Gill, Parkash

Report Date:

2021-10-01

Pagination or Media Count:

10

Abstract:

Descriptors:

• cell line
• breast cancer
• cell physiological processes
• cells
• neoplasms
• proteins
• standards
• targets
• tissues
• tyrosine
• biomedical research
• cytotoxins
• department of defense
• membranes
• survival
• california
• mass spectrometry

Subject Categories:

Distribution Statement:

[A, Approved For Public Release]